Myungmoon Pharmaceutical, Stock Price 6510 Won (1.88%)... Bulletin Board 'Bustling'

At this time, posts about Myungmoon Pharmaceutical are rapidly increasing on portals and stock communities. Today, foreign investors have sold a net 160,000 shares of Myungmoon Pharmaceutical, while institutions have sold a net 25,000 shares, according to preliminary data. Myungmoon Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.

As of 12:30 PM on the 7th, the stock price of Myungmoon Pharmaceutical is 6,510 KRW, up 1.88% from the previous day, with a trading volume of 9,534,390 shares, which is 138.89% of the 5-day average trading volume. On August 5th, Myungmoon Pharmaceutical became a market issue with the news "US researchers discover COVID-19 inhibitor... Highlighting drug production history."

In addition to Myungmoon Pharmaceutical, posts by investors are also rapidly increasing for Yuyu Pharmaceutical 1 Preferred (000225), OrbiTech (046120), and Hanmi Science (008930).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.